Viridos (formerly Synthetic Genomics, Inc.) is a California-based biotechnology company
harnessing the power of photosynthesis to create transformative solutions to mitigate climate change.
Founded in 2005 by leading figures in synthetic biology, including J Craig Venter and Hamilton Smith, Synthetic Genomics now Viridos quickly established itself as a powerhouse for innovative research, transplanting the first genome, synthesizing the first bacterial genome, and creating the first synthetic cell.
Over the past 16 years, we’ve created a legacy of genomic innovations, building the tools, scientific data, and applied knowledge to address unsolved challenges in pharmaceuticals, energy, and life sciences.
We’re concentrating our algal genomics expertise on decarbonizing heavy transportation.
Our name change to Viridos reflects that single-minded focus, referencing the Latin word viridis, meaning green, fresh, and lively. More importantly, our work with microalgae to decarbonize entire industries and create products that are in harmony with nature will provide the solutions needed for a greener and more prosperous future.
In partnership with ExxonMobil, our initial deployment is a scalable platform for low-carbon intensity biofuels, which can reduce greenhouse gas emissions from aviation, commercial trucking, and maritime shipping by nearly 70%. By establishing desert-based production sites to grow Viridos-engineered microalgae in saltwater, we’re creating the foundation for a biofuel future that moves away from fossil fuels without competing for precious resources such as fresh water and arable land.